Julian Larcher‐Senn

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl et al. · The Lancet · 2023 · 192 citations · Full text

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial

Nina Wressnigg, Romana Hochreiter, Oliver Zoihsl et al. · The Lancet Infectious Diseases · 2020 · 98 citations

Vaccination, Vaccine Safety, Vaccinology +7

Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study

Lisa Pleyer, Michael Leisch, Alexandra Kourakli et al. · The Lancet Haematology · 2021 · 52 citations

Hematological Malignancy, Non-curative Therapies, Retrospective Cohort Study +8

Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults

Nicole Bézay, Romana Hochreiter, Vera Kadlecek et al. · The Lancet Infectious Diseases · 2023 · 37 citations

Vaccination, Vaccine Development, Vaccine Research +9

Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies

Nicole Bézay, Laura Danielle Wagner, Vera Kadlecek et al. · The Lancet Infectious Diseases · 2024 · 25 citations

Vaccination, Vaccine Safety, Dose Level +8